Deep Lens is extending one of the World's first digital pathology cloud platforms that for over ten years has allowed pathology groups to collaborate on groundbreaking cancer research across dozens of cancer types.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
10/15/18 | $3,200,000 | Seed |
Rev1 Ventures Sienna Ventures Tamarind Hill | undisclosed |